Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, United States.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States; Institute for Hospital Management, School of Medicine, Tsinghua University, Beijing, China; Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States.
Am J Clin Nutr. 2024 Feb;119(2):302-313. doi: 10.1016/j.ajcnut.2023.11.017. Epub 2023 Nov 30.
Previous literature on dairy products and risk of breast cancer is inconsistent, and the relationship may depend on the life-period of dietary assessment.
We examined dairy consumption from adolescence through later adulthood and incidence of breast cancer by menopausal status and tumor molecular subtypes in the Nurses' Health Study (NHS), a prospective cohort study.
We analyzed data from 63,847 females in the NHS collected from 1980 to 2018. Average intake of dairy products during adulthood was assessed by validated semiquantitative food frequency questionnaires throughout follow-up. Participants recalled adolescent dietary intake in 1986. Multivariable Cox proportional hazards models were used to estimate hazard ratios (HRs) relating dairy product consumption to breast cancer risk overall, by menopausal status, and by subtypes.
We documented 5733 incident cases of invasive breast cancer during 32 y of follow-up (n = 5298 postmenopausal). Lifetime, adolescent, adulthood, and postmenopausal total dairy and milk intakes were not associated with overall breast cancer risk (nonsignificant HRs comparing highest with lowest quintile range = 0.97-1.08), although there was a suggestive positive association between adolescent milk intake and breast cancer risk (HR: 1.09; 95% CI: 1.00, 1.18). Higher lifetime and premenopausal cheese intakes were associated with modestly lower risks of breast cancer (comparing highest with lowest quintile, HR for lifetime cheese intake: 0.90; 95% CI: 0.82, 0.98; HR for premenopausal cheese intake: 0.89; 95% CI: 0.79, 1.00). Results varied by tumor subtype and some evidence for heterogeneity was observed for an association between premenopausal milk intake and breast cancer (HR for estrogen receptor [ER]-positive: 0.84; 95% CI: 0.72, 0.99; ER-negative: 1.36; 95% CI: 1.00, 1.84; P heterogeneity = 0.04).
These findings suggest that overall dairy consumption was not associated with risk of breast cancer. However, heterogeneity was observed for type of dairy food, period of life, and tumor subtypes.
之前关于乳制品与乳腺癌风险的文献结果并不一致,这种关联可能取决于饮食评估的生命阶段。
我们通过前瞻性队列研究护士健康研究(NHS),检查了青春期至成年后期的乳制品摄入与绝经状态和肿瘤分子亚型的乳腺癌发病之间的关系。
我们分析了 NHS 中 63847 名女性的数据,这些数据是从 1980 年到 2018 年收集的。通过整个随访期间的验证半定量食物频率问卷评估成年期的乳制品平均摄入量。参与者在 1986 年回忆了青春期的饮食摄入情况。多变量 Cox 比例风险模型用于估计与乳制品摄入相关的风险比(HR),以整体、绝经状态和亚型来评估乳腺癌风险。
在 32 年的随访中,我们记录了 5733 例浸润性乳腺癌病例(绝经后 5298 例)。终身、青春期、成年期和绝经后总乳制品和牛奶摄入量与总体乳腺癌风险无关(最高与最低五分位数范围的非显著 HR 为 0.97-1.08),尽管青春期牛奶摄入量与乳腺癌风险之间存在提示性正相关(HR:1.09;95%CI:1.00,1.18)。较高的终生和绝经前奶酪摄入量与乳腺癌风险适度降低相关(终生奶酪摄入量最高与最低五分位数比较的 HR:0.90;95%CI:0.82,0.98;绝经前奶酪摄入量的 HR:0.89;95%CI:0.79,1.00)。结果因肿瘤亚型而异,并且观察到绝经前牛奶摄入量与乳腺癌之间的关联存在一些异质性证据(雌激素受体 [ER]-阳性的 HR:0.84;95%CI:0.72,0.99;ER-阴性的 HR:1.36;95%CI:1.00,1.84;P 异质性=0.04)。
这些发现表明,总体乳制品的摄入与乳腺癌的发病风险无关。然而,对于乳制品的类型、生命阶段和肿瘤亚型,观察到了异质性。